Naomi Visanji*
Email: naomi.visanji@uhnresearch.ca
Tanz Centre for Research in Neurodegenerative Diseases, Unversity of Toronto
Collaborative Program in Neuroscience (CPIN) member
Research interests: Dr Visanji completed her PhD in Pharmacology at Kings College London (UK) in 2004 and following that relocated to Canada where she holds an appointment at both the University of Toronto department of Laboratory Medicine and Pathobiology and Edmond J. Safra program in Parkinson's disease at Toronto Western Hospital. Dr Visanji’s research focuses on the pathobiology of alpha synuclein in Parkinson’s disease including the detection of peripheral alpha synuclein as a biomarker. Dr Visanji has published over 50 peer reviewed publications in the field of Parkinson’s disease research and drug development. She is also a Senior Scientist at Rosetta Therapeutics, a University of Toronto/MaRS Innovation UTEST startup developing new molecular matter as leads for the cure of neurodegenerative diseases.
Assistant Professor
Department of Laboratory Medicine and Pathobiology - SGS Appointment
University of Toronto
Principal Investigator
Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto
Scientific Associate
Edmond J Safra Program in Parkinson Disease and Rossy Program in Progressive Supranuclear Palsy
Toronto Western Hospital